Heparina Sódica Sala (Heparin Sodium)

Heparina Sódica Sala is employed in clinical settings where rapid anticoagulation is required. It is indicated for several therapeutic situations:

• Prevention of clot formation during haemodialysis sessions.
• Intra‑arterial anticoagulation during interventional radiology or cardiac catheterisation.
• Intravenous anticoagulation for patients with acute thrombotic disorders.
• Supportive therapy in surgeries that carry a high risk of thrombosis.
• Management of extracorporeal circulation circuits such as cardiopulmonary bypass.

Heparina Sódica Sala may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common

• Minor bleeding at the infusion site.
• Small bruising or ecchymoses.
• Transient elevation of liver enzymes.
• Mild nausea or vomiting.
• Localised pain or irritation at the injection site.

Serious

• Major hemorrhage, including internal bleeding.
• Heparin‑induced thrombocytopenia (HIT).
• Allergic reactions such as urticaria or anaphylaxis.
• Spontaneous spinal or epidural hematoma.
• Severe hypotension due to rapid infusion.

Before using Heparina Sódica Sala, clinicians should consider several safety factors to minimise risk. Important precautions include:

• Assess patient history for bleeding disorders or recent surgery.
• Monitor activated partial thromboplastin time (aPTT) or anti‑Xa levels during therapy.
• Use reduced doses in patients with renal impairment or the elderly.
• Avoid use in individuals with known hypersensitivity to heparin or pork products.
• Evaluate pregnancy status; the safety profile is not well established.
• Discontinue promptly if signs of heparin‑induced thrombocytopenia appear.

Heparina Sódica Sala can interact with other medications, influencing its anticoagulant effect or increasing bleeding risk.

Avoid

• Concurrent use of other anticoagulants (e.g., warfarin, direct oral anticoagulants).
• High‑dose antiplatelet agents such as clopidogrel or aspirin.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that impair platelet function.

Use with caution

• Thrombolytic agents (e.g., alteplase) during acute clot dissolution.
• Certain antibiotics like vancomycin that may potentiate anticoagulation.
• Herbal supplements with anticoagulant properties (e.g., ginkgo, garlic).
• Corticosteroids that may affect vascular integrity.